Watanabe Todd Franklin - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 2, 2024, Watanabe Todd Franklin's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Director,Officer (See Remarks), and currently has 846,263 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ARQT insiders.

Data Source: SEC.
Watanabe Todd Franklin - Insider Non-Derivative Transactions of ARQT Common Stock
Watanabe Todd Franklin - Insider Non-Derivative Transactions at ARQT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 3, 2024 Sell -- (Common Stock) 14487 9.02 846263
May 3, 2024 Sell -- (Common Stock) 13783 8.74 860750
Mar 5, 2024 Sell -- (Common Stock) 14903 11.12 874533
Feb 29, 2024 Sell -- (Common Stock) 2465 10.6 889436
Feb 14, 2024 Acquisition -- (Common Stock) 21666 0 648685
Feb 14, 2024 Acquisition -- (Common Stock) 33066 0 681751
Feb 14, 2024 Acquisition -- (Common Stock) 94050 0 775801
Feb 14, 2024 Acquisition -- (Common Stock) 116100 0 891901
Jan 13, 2024 Acquisition -- (Common Stock) 125000 0 627019
Dec 21, 2023 G -- (Common Stock) 6563 0 24413
Dec 21, 2023 G -- (Common Stock) 6563 0 502019
Dec 21, 2023 G -- (Common Stock) 6563 0 508582
Dec 2, 2023 M -- (Common Stock) 59525 1.68 513682
Jun 1, 2023 P -- (Common Stock) 1463 6.38 515145
Mar 7, 2023 Sell -- (Common Stock) 2435 15.26 366657
Mar 3, 2023 Sell -- (Common Stock) 69 16.52 369092
Mar 3, 2023 Sell -- (Common Stock) 5403 15.82 369161
Mar 3, 2023 Acquisition -- (Common Stock) 87500 0 456592
Mar 1, 2023 Sell -- (Common Stock) 2343 16.17 374564
Feb 15, 2023 Sell -- (Common Stock) 100 17.03 376907
Feb 15, 2023 Sell -- (Common Stock) 417 17.02 377007
Feb 14, 2023 Sell -- (Common Stock) 42 17.01 377424
Feb 14, 2023 Sell -- (Common Stock) 441 17 377466
Feb 2, 2023 Sell -- (Common Stock) 382 17 377907
Feb 2, 2023 Sell -- (Common Stock) 618 17 378289